NCT05641129

Brief Summary

APOLLO (Acute PresentatiOn of CoLorectaL Cancer: an internatiOnal snapshot) is an international, multi-centre, prospective observational study which will address this need and aims to describe the operative and non-operative management of emergency presentations of colon and rectal cancer in an international cohort.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 17, 2022

Completed
20 days until next milestone

First Posted

Study publicly available on registry

December 7, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

January 16, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 11, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 11, 2023

Completed
Last Updated

February 20, 2024

Status Verified

February 1, 2023

Enrollment Period

8 months

First QC Date

November 17, 2022

Last Update Submit

February 15, 2024

Conditions

Keywords

colorectal surgerycolorectal cancercolonic stentingemergency surgery

Outcome Measures

Primary Outcomes (1)

  • Primary outcome

    Mortality since day of presentation

    90-day

Secondary Outcomes (9)

  • Secondary outcome 1

    30-day

  • Secondary outcome 2

    30- and 90-day

  • Secondary outcome 3

    30- and 90-day

  • Secondary outcome 4

    30- and 90-day

  • Secondary outcome 5

    90-day

  • +4 more secondary outcomes

Study Arms (1)

Main Cohort

Consecutive adult patients (≥18 years of age) presenting acutely (i.e. unplanned and non-elective presentation to hospital for urgent or emergency reasons) for symptoms of known or unknown colorectal cancer assessed by hospital surgical teams. Patients should be included regardless of operative or non-operative management, and curative or palliative intent.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Consecutive adult patients (≥18 years of age) presenting acutely (i.e. unplanned and non-elective presentation to hospital for urgent or emergency reasons) for symptoms of known or unknown colorectal cancer assessed by hospital surgical teams. Patients should be included regardless of operative or non-operative management, and curative or palliative intent.

You may qualify if:

  • Patient pathology: Patients admitted to the hospital acutely with primary colon AND/OR rectal adenocarcinoma and referred to general/colorectal surgical departments:
  • Patients who are operated on for curative/palliative treatment of colorectal cancer
  • Patients who are referred to general surgery for assessment (irrespective of if they proceed to surgery)
  • New diagnoses of colorectal cancer
  • Extent of cancer: All patients including extra-abdominal metastatic, intra-abdominal metastatic and non-metastatic disease
  • Known cancer: Patients presenting for the first time with colorectal cancer AND/OR known colorectal cancer diagnosis with progression of disease. i.e. obstruction of known colorectal cancer
  • Patient presentation: Symptomatic presentation of colorectal cancer i.e. large bowel obstruction, haemorrhage, perforation

You may not qualify if:

  • Presenting for side effects of cancer treatment
  • Patients with secondary cancers
  • Previously included in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aberdeen Royal Infirmary

Aberdeen, Ireland, United Kingdom

Location

Related Publications (1)

  • EuroSurg Collaborative and STARSurg Collaborative. Global Use and Outcomes of Endoscopic Stenting in Acute Malignant Left-Sided Colonic Obstruction: A Secondary Analysis of APOLLO, An International, Prospective Cohort Study. Dis Colon Rectum. 2025 Dec 1;68(12):1458-1467. doi: 10.1097/DCR.0000000000003960. Epub 2025 Oct 10.

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 17, 2022

First Posted

December 7, 2022

Study Start

January 16, 2023

Primary Completion

September 11, 2023

Study Completion

November 11, 2023

Last Updated

February 20, 2024

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Centre-summaries will be made available to respective centres for audit purposes.

Locations